Adenomatous Polyps
Also known as: Adenomatous Polyposis / Polyp, Adenomatous / Adenomatous Polyp / Polyposis Coli / Familial Polyposis / Adenomatous Polyposis Coli / Adenomatous polyp (morphologic abnormality) / Benign neoplasm of other and unspecified female genital organs / Familial adenomatous polyposis / Familial multiple polyposis syndrome (disorder) / MYH-associated polyposis (disorder) / Adenomatous polyposis coli (morphologic abnormality) / Familial Intestinal Polyposis / Multiple adenomatous polyps (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 1 | Completed | 1 |
DB11834 | Guselkumab | 1 | Completed | 1 |
DB00945 | Acetylsalicylic acid | 2 | Completed | 1 |
DB06243 | Eflornithine | 2 | Completed | 1 |
DB00530 | Erlotinib | 2 | Completed | 2 |
DB00638 | Inulin | 2 | Unknown Status | 1 |
DB00331 | Metformin | 2 | Completed | 1 |
DB00877 | Sirolimus | 2 | Completed | 1 |
DB00605 | Sulindac | 2 | Completed | 1 |
DB00605 | Sulindac | 2 | Unknown Status | 1 |
DB00159 | Icosapent | 2 / 3 | Completed | 1 |
DB00945 | Acetylsalicylic acid | 3 | Terminated | 1 |
DB00136 | Calcitriol | 3 | Terminated | 1 |
DB06724 | Calcium carbonate | 3 | Terminated | 1 |
DB00482 | Celecoxib | 3 | Terminated | 1 |
DB00533 | Rofecoxib | 4 | Terminated | 1 |
DB00693 | Fluorescein | Not Available | Terminated | 1 |
DB11834 | Guselkumab | Not Available | No Longer Available | 1 |